Directiva 2011/78/UE de la Comisión, de 20 de septiembre de 2011, por la que se modifica la Directiva 98/8/CE del Parlamento Europeo y del Consejo de forma que incluya Bacillus thuringiensis, subsp. israelensis, serotipo H14, cepa AM65-52, como sustancia activa en su anexo I
› ›
Enlazado como:Extracto
Directiva 2011/78/UE de la Comisión, de 20 de septiembre de 2011, por la que se modifica la Directiva 98/8/CE del Parlamento Europeo y del Consejo de forma que incluya Bacillus thuringiensis, subsp. israelensis, serotipo H14, cepa AM65-52, como sustancia activa en su anexo I
No longer available (Autolink)
Ver el contenido completo de este documento
Afectaciones
MODIFICA
INCORPORADA por
Documentos citados
- Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market
- Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
- Commission Directive 2011/78/EU of 20 September 2011 amending Directive 98/8/EC of the European Parliament and of the Council to include Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 as an active substance in Annex I thereto Text with EEA relevance
- Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
- Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
